In this column for The Wall Street Journal’s Think Tank, Drew Altman lays out the news media’s challenge covering the upcoming Supreme Court King v. Burwell decision about the ACA.
- view as grid
- view as list
New Analysis Details Impact on Residents in Different States If the U.S. Supreme Court Rules for Challengers in King v. Burwell
The U.S. Supreme Court is expected to rule this month in the King v. Burwell case that challenges whether low- and moderate-income Americans are eligible for subsidies to help pay for insurance if they live in states where the federal government, rather than the state, established its new insurance marketplace…
Larry Levitt’s March 2015 post explores what could happen if the U.S. Supreme Court rules for the plaintiffs in the King v. Burwell case, the lawsuit that challenges the federal government’s authority to provide financial assistance to people who buy insurance in federally-operated marketplaces created by the Affordable Care Act.
The Affordable Care Act (ACA) requires most private health insurance plans to provide coverage for a broad range of preventive services including FDA approved prescription contraceptives and services for women. Legal challenges and recently issued rules have affected contraceptive coverage for many women.
This short fact sheet answers questions about how where a woman works may affect the contraceptive coverage she may receive.
This issue brief examines the federal courts’ role to date in interpreting and affecting implementation of the Affordable Care Act (ACA), with a focus on the provisions that seek to expand access to affordable coverage.
The latest Kaiser Health Tracking Poll finds though few Americans are paying attention to the pending Supreme Court case over whether the health care law says that people in all states can get financial help to buy health insurance, most say they would want Congress and their state to act to fix potential gaps should the Supreme Court rule in favor of the plaintiffs. With a new Republican majority controlling both Houses of Congress, the public remains divided on what they would like Congress to do next with the Affordable Care Act (ACA) overall. About a third (32%) say they favor repeal, another 14 percent would like the law scaled back, 19 percent want the law to move forward as is, and nearly a quarter (23%) would like to see the law expanded.
With a Supreme Court decision on King v. Burwell looming, Drew Altman’s latest column for The Wall Street Journal’s Think Tank plays out the politics of a ruling for the two major parties. All previous columns by Drew Altman are available.
In his latest column for The Wall Street Journal’s Think Tank, Drew Altman lays out the news media’s challenge covering the upcoming Supreme Court King v. Burwell decision about the Affordable Care Act. All previous columns by Drew Altman are available online.
Given recent news about some high-cost prescription drugs and the debate about who should pay for them, this month’s Kaiser Health Tracking Poll has a special focus on the issue. Nearly three-quarters of the public think that the cost of prescription drugs is unreasonable. Americans place much of the blame with the drug companies saying they set prices too high and that company profits are a major factor in drug pricing. The poll also finds that most of the public still hasn’t heard much about the Supreme Court case on whether people in states with federal marketplaces are eligible for financial assistance to purchase health insurance. Most feel that Congress and states should act if the Court rules for the plaintiffs, but there is no agreement among partisans.